European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 251-256 , March 2010

Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum – Toxicity and complications of the treatment

  • R. Soumarova

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 556 794 180.
    • ,
  • M. Skrovina

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
    • ,
  • J. Bartos

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
    • ,
  • J. Gruna

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
    • ,
  • A. Wendrinski

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
    • ,
  • S. Czudek

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
    • ,
  • R. Kycina

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
    • Surgical Clinic of Martin Faculty Hospital, Jessenius Medical Faculty of Commenius University, Martin, Slovakia
    • ,
  • J. Parvez

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic

,Accepted 1 October 2009.

References 

  1. Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta–analysis. JAMA. 2000;284:1008–1015
  2. Glimelius B, Isacsson U, Jung B, et al. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose–response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys. 1997;37:281–287
  3. Rodel C, Grabenbauer GG, Schick C, et al. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4–primary rectal cancer. Strahlenther Onkol. 2000;176(4):161–167
  4. Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921. J Clin Oncol. 2005;23(24):5620–562720
  5. Sauer R, Becker H, Hohenberger W, et al. German rectal cancer study group, preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740
  6. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:1025–1029
  7. Ngan SY, Michael M, Mackay J, et al. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer. 2004;91:1019–1024
  8. Dupuis O. Capecitabine (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: a phase II GERCOR trial. Abstract 3538 Proc Am J Clin Oncol. 2004;23:255
  9. Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first–line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol. 2001;19:2282–2292
  10. Feliciotti F, Paganini AM, Guerrieri M, et al. Results of laparoscopic vs open resections for colon cancer in patients with a minimum follow–up of 3 years. Surg Endosc. 2002;16:1158–1161
  11. Jacob BP, Salky B. Laparoscopic colectomy for colon adenocarcinoma. Surg Endosc. 2005;19:643–649
  12. International Union Against Cancer (UICC) . TNM klasifikace zhoubnych novotvaru, seste vydani 2002. Praha: Ustav Zdravotnickych Informaci a Statistiky Ceske Republiky; 2004;ISBN 80–7280–391–365–68
  13. Capecitabine Dupuis O. (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: a phase II GERCOR trial. Abstract 3538 Proc Am J Clin Oncol. 2004;23:255
  14. Wong SJ, Sadasiwan C, Erickson B, et al. A phase II trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer. abstract 281 Proc Am Soc Clin Oncol Gastrointest Cancer Symp. 2004;
  15. Krishnan S, Janjan NA, Skibber JM, et al. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006;66:762–771
  16. Velenik V, Anderluh F, Oblak I, et al. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. Croat Med J. 2006;47:693–700
  17. Korkolis DP, Boskos CS, Plataniotis GD, et al. Pre–operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res. 2007;27(1B):541–545
  18. JCh Kim, Kim TW, Kim JH, et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2005;63(2):346–353
  19. Craven I, Crellin A, Cooper R, et al. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97(10):1333–1337
  20. Kocakova I, Svoboda M, Kubosova K, et al. Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma. Neoplasma. 2007;54(5):447–453
  21. de Bruin AF, Nuyttens JJ, Ferenschild FT, et al. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med. 2008;66(2):71–76
  22. Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol. 2008;97(1):8–13
  23. Wichmann MW, Muller C, Meyer G, et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg. 2002;137:206–210
  24. Skrovina M, Bartos J, Soumarova R, et al. Laparocopic resection of rectal cancer: evaluation of perioperative results of the primary resection and resection after preoperative chemoradiotherapy. Rozhl Chir. 2008;87:417–425
  25. Kim JS, Sung J, Cho MJ, et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiation Oncology Biol Phys. 2002;55:403–408
  26. Matthiessen P, Hallbook O, Rutegard J, et al. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer, a randomized multicenter trial. Ann Surg. 2007;246:207–214
  27. Klautke G, Kuchenmeister U, Foitzik T, et al. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer. 2006;94:976–981
  28. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging–defined poor–risk rectal cancer. J Clin Oncol. 2006;24:668–674
  29. Machiels JP, Duck L, Honhon B, et al. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol. 2005;16:1898–1905
  30. Rodel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol. 2003;21:3098–3104

PII: S0748-7983(09)00471-5

doi: 10.1016/j.ejso.2009.10.002

European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 251-256 , March 2010

Article Tools